Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.

Autor: Aguareles J; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Facultad de Ciencias Biomédicas y de la Salud, Medicine Department, Universidad Europea de Madrid, Madrid, Spain.; Research and Clinical Trials Unit, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Villares Fernández P; Internal Medicine Department, Hospital Universitario HM Sanchinarro, Madrid, Spain., Forné C; Heorfy Consulting, Lleida, Spain.; Basic Medical Sciences Department, University of Lleida, Lleida, Spain., Martí-Ballesteros EM; Facultad de Ciencias Biomédicas y de la Salud, Medicine Department, Universidad Europea de Madrid, Madrid, Spain.; Haematology Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Pradillo Fernández V; Facultad de Ciencias Biomédicas y de la Salud, Medicine Department, Universidad Europea de Madrid, Madrid, Spain.; Haematology Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Sotres-Fernandez G; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Facultad de Ciencias Biomédicas y de la Salud, Medicine Department, Universidad Europea de Madrid, Madrid, Spain., de la Fuente-Burguera A; Haematology and Haemotherapy Service, MD Anderson Cancer Center, Madrid, Spain., Navarro-San Francisco C; Infectious Diseases Unit, Internal Medicine Department, Hospital Universitario de Burgos, Burgos, Spain., Buzón-Martín LM; Infectious Diseases Unit, Internal Medicine Department, Hospital Universitario de Burgos, Burgos, Spain., García-Delangue T; Internal Medicine Department, Hospital HLA Universitario Moncloa, Madrid, Spain., Aiello FT; Internal Medicine Department, Hospital Clinic de Barcelona, Barcelona, Spain., Carnevali-Ruiz D; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Facultad de Ciencias Biomédicas y de la Salud, Medicine Department, Universidad Europea de Madrid, Madrid, Spain., Lloris R; VirologyUnit, PharmaMar S.A., Madrid, Spain., Luepke-Estefan XE; Coordinator of Compassionate Drug Use, PharmaMar S.A., Madrid, Spain., López-Martín JA; VirologyUnit, PharmaMar S.A., Madrid, Spain., Jimeno JM; VirologyUnit, PharmaMar S.A., Madrid, Spain., García-Casas A; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Research and Clinical Trials Unit, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Guisado-Vasco P; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Facultad de Ciencias Biomédicas y de la Salud, Medicine Department, Universidad Europea de Madrid, Madrid, Spain.

Publikováno v: Infectious diseases (London, England) [Infect Dis (Lond)] 2024 Jul; Vol. 56 (7), pp. 575-580. Date of Electronic Publication: 2024 May 14.

Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia

Autor: Guisado-Vasco, P., Carralón-González, M. M., Aguareles-Gorines, J., Martí-Ballesteros, E. M., Sánchez-Manzano, M. D., Carnevali-Ruiz, D., García-Coca, M., Barrena-Puertas, R., de Viedma, R. García, Luque-Pinilla, J. M., Sotres-Fernandez, G., Fernández-Sousa, J. M., Luepke-Estefan, X. E., López-Martín, J. A., Jimeno, J. M.

Publikováno v: Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-4 (2022)
Journal of Hematology & Oncology

BackgroundThere is an urgent need for highly efficacious antiviral therapies in immunosuppressed hosts who develop coronavirus disease (COVID-19), with special concern for those affected by hematological malignancies.Case presentationHere, we report

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::716a47ac2bc1add5646c5348b59cb8fd
https://doi.org/10.1186/s13045-021-01220-0

Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.

Autor: Guisado-Vasco P; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Universidad Europea, Madrid, Spain., Aguarles Gorines J; Research and Clinical Trials Unit, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Carralón González MM; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Universidad Europea, Madrid, Spain., Sotres Fernández G; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Universidad Europea, Madrid, Spain., Carnevali Ruiz D; Internal Medicine Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.; Universidad Europea, Madrid, Spain.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2022 Aug 12; Vol. 226 (1), pp. 1-5.

Cyclosporine A and COVID19 - The COQUIMA cohort - Author's reply.

Autor: Guisado-Vasco P; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Carnevali-Ruiz D; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Vasallo IJT; Statistical section, Faculty of Biomedical Science and Health, Universidad Europea (Madrid), Villaciosa de Odon, Madrid, Spain.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2021 Jan; Vol. 31, pp. 100682. Date of Electronic Publication: 2020 Dec 24.

Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).

Autor: Guisado-Vasco P; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Valderas-Ortega S; Nurse. Hospital Infectious Diseases Control Unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Carralón-González MM; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Roda-Santacruz A; Research coordinator. Research and clinical trials unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., González-Cortijo L; Department of Oncology. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Sotres-Fernández G; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Martí-Ballesteros EM; Department of Hematology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Luque-Pinilla JM; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Almagro-Casado E; Department of Oncology. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., La Coma-Lanuza FJ; Intensive Care Unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Barrena-Puertas R; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Malo-Benages EJ; Department of Angiology and Vascular Surgery, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Monforte-Gómez MJ; Department of Internal Medicine, Hospital quironsalud San Jose, Madrid, Spain., Diez-Munar R; Department of Anesthesiology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Merino-Lanza E; Department of Cardiology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Comeche-Casanova L; Department of Pneumology, Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Remirez-de-Esparza-Otero M; Pharmacy Unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Correyero-Plaza M; Department of Rheumatology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Recio-Rodríguez M; Department of Radiology department, Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Rodríguez-López M; Department of Endocrinology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Sánchez-Manzano MD; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Andreu-Vázquez C; Statistical section, Faculty of Biomedical Science and Health, Universidad Europea (Madrid), Villaciosa de Odón, Madrid, Spain., Thuissard-Vasallo IJ; Statistical section, Faculty of Biomedical Science and Health, Universidad Europea (Madrid), Villaciosa de Odón, Madrid, Spain., María-Tomé JME; Department of Pneumology, Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Carnevali-Ruiz D; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2020 Nov; Vol. 28, pp. 100591. Date of Electronic Publication: 2020 Oct 15.